SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-000948
Filing Date
2021-08-05
Accepted
2021-08-05 16:29:19
Documents
65
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q kpti-20210630.htm   iXBRL 10-Q 2588308
2 EX-10.2 kpti-20210630ex10_2.htm EX-10.2 37656
3 EX-31.1 kpti-20210630ex31_1.htm EX-31.1 11711
4 EX-31.2 kpti-20210630ex31_2.htm EX-31.2 11751
5 EX-32.1 kpti-20210630ex32_1.htm EX-32.1 6875
6 EX-32.2 kpti-20210630ex32_2.htm EX-32.2 7276
  Complete submission text file 0000950170-21-000948.txt   9066094

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kpti-20210630_pre.xml EX-101.PRE 423964
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT kpti-20210630_cal.xml EX-101.CAL 50556
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT kpti-20210630_lab.xml EX-101.LAB 522629
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT kpti-20210630_def.xml EX-101.DEF 300248
11 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kpti-20210630.xsd EX-101.SCH 61396
12 EXTRACTED XBRL INSTANCE DOCUMENT kpti-20210630_htm.xml XML 1640350
Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Filer) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36167 | Film No.: 211148758
SIC: 2834 Pharmaceutical Preparations